Trump says Iran war "close to over" amid hopes for more negotiations
Celanese stock reached a 52-week high of $63.55, reflecting growing investor confidence in the company’s performance. The stock’s momentum has been particularly strong in recent months, with a 51% surge over the past six months and a 46% gain year-to-date, though the full-year return stands at approximately 6%. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value, suggesting investors should weigh the recent momentum against valuation metrics. This milestone comes as Celanese continues to navigate through a dynamic economic landscape, leveraging its strategic initiatives to bolster its market position. InvestingPro rates the company’s overall financial health as "GOOD" with a score of 2.59 out of 5, while InvestingPro Tips highlight that net income is expected to grow this year. For deeper insights, investors can access Celanese’s comprehensive Pro Research Report, one of 1,400+ available reports transforming complex data into actionable intelligence.
In other recent news, Celanese Corporation announced several price increases across its product lines. The company raised prices for its acetyl products globally, with acetic acid increasing by $0.10 per pound and vinyl acetate monomer by $0.25 per pound in the Americas. Additionally, ethyl acetate and acetic anhydride will see price hikes of $0.20 and $0.15 per pound, respectively. Starting April 1, 2026, Celanese will also implement price increases on its engineered materials products, with POM products rising by $0.09 per pound in the Americas and €0.50 per kilogram in EMEA.
In leadership changes, Timothy Go has resigned from the Celanese Board of Directors, effective February 27, 2026. His resignation was not due to any disagreements with the company. On the analyst front, RBC Capital raised its price target for Celanese to $55, highlighting the company’s focus on cash generation despite challenging conditions. Meanwhile, BofA Securities increased its price target to $70, citing attractive valuation and signs of earnings recovery. These developments reflect ongoing strategic adjustments and market perceptions of Celanese.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.